Dimitrios I Zaridis, Vasileios C Pezoulas, Eugenia Mylona, Charalampos N Kalantzopoulos, Nikolaos S Tachos, Nikos Tsiknakis, George K Matsopoulos, Daniele Regge, Nikolaos Papanikolaou, Manolis Tsiknakis, Kostas Marias, Dimitrios I Fotiadis
{"title":"Simplatab: An Automated Machine Learning Framework for Radiomics-Based Bi-Parametric MRI Detection of Clinically Significant Prostate Cancer.","authors":"Dimitrios I Zaridis, Vasileios C Pezoulas, Eugenia Mylona, Charalampos N Kalantzopoulos, Nikolaos S Tachos, Nikos Tsiknakis, George K Matsopoulos, Daniele Regge, Nikolaos Papanikolaou, Manolis Tsiknakis, Kostas Marias, Dimitrios I Fotiadis","doi":"10.3390/bioengineering12030242","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prostate cancer (PCa) diagnosis using MRI is often challenged by lesion variability.</p><p><strong>Methods: </strong>This study introduces Simplatab, an open-source automated machine learning (AutoML) framework designed for, but not limited to, automating the entire machine Learning pipeline to facilitate the detection of clinically significant prostate cancer (csPCa) using radiomics features. Unlike existing AutoML tools such as Auto-WEKA, Auto-Sklearn, ML-Plan, ATM, Google AutoML, and TPOT, Simplatab offers a comprehensive, user-friendly framework that integrates data bias detection, feature selection, model training with hyperparameter optimization, explainable AI (XAI) analysis, and post-training model vulnerabilities detection. Simplatab requires no coding expertise, provides detailed performance reports, and includes robust data bias detection, making it particularly suitable for clinical applications.</p><p><strong>Results: </strong>Evaluated on a large pan-European cohort of 4816 patients from 12 clinical centers, Simplatab supports multiple machine learning algorithms. The most notable features that differentiate Simplatab include ease of use, a user interface accessible to those with no coding experience, comprehensive reporting, XAI integration, and thorough bias assessment, all provided in a human-understandable format.</p><p><strong>Conclusions: </strong>Our findings indicate that Simplatab can significantly enhance the usability, accountability, and explainability of machine learning in clinical settings, thereby increasing trust and accessibility for AI non-experts.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 3","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11939345/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12030242","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Prostate cancer (PCa) diagnosis using MRI is often challenged by lesion variability.
Methods: This study introduces Simplatab, an open-source automated machine learning (AutoML) framework designed for, but not limited to, automating the entire machine Learning pipeline to facilitate the detection of clinically significant prostate cancer (csPCa) using radiomics features. Unlike existing AutoML tools such as Auto-WEKA, Auto-Sklearn, ML-Plan, ATM, Google AutoML, and TPOT, Simplatab offers a comprehensive, user-friendly framework that integrates data bias detection, feature selection, model training with hyperparameter optimization, explainable AI (XAI) analysis, and post-training model vulnerabilities detection. Simplatab requires no coding expertise, provides detailed performance reports, and includes robust data bias detection, making it particularly suitable for clinical applications.
Results: Evaluated on a large pan-European cohort of 4816 patients from 12 clinical centers, Simplatab supports multiple machine learning algorithms. The most notable features that differentiate Simplatab include ease of use, a user interface accessible to those with no coding experience, comprehensive reporting, XAI integration, and thorough bias assessment, all provided in a human-understandable format.
Conclusions: Our findings indicate that Simplatab can significantly enhance the usability, accountability, and explainability of machine learning in clinical settings, thereby increasing trust and accessibility for AI non-experts.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering